Pharmaceutical markets experience the entry of numerous generic firms upon expiration of the brand firm's patent. In … this paper, we take a close look at competition among the generic entrants during the first three years after patent …. The model is estimated on cross-section time-series data for 49 molecules in which the brand drug lost patent exclusivity …